Global Biotechnology/Pharmaceutical Services Outsourcing Market Size, Status and Forecast 2018-2025
This report focuses on the global Biotechnology/Pharmaceutical Services Outsourcing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Biotechnology/Pharmaceutical Services Outsourcing development in United States, Europe and China.
When it comes to pharmaceutical research and development however, success is never guaranteed. The average cost of drug development can reach into the billions of dollars, and it takes an average of 10 years to bring a new drug to market. In addition, many drugs fail to be clinical effective and subsequently never see the light of day.
Due to these risks, pharmaceutical companies are not always eager to utilize their onsite resources for drug R&D. Certain cost-saving measures implemented in the pharmaceutical space have included outsourcing these activities, helping organizations reduce both their operational and manufacturing costs, thereby lowering financial risk.
North America held more than 50.0% share for the pharmaceutical/biotechnology services outsourcing market in 2015. The presence of several multinational and local consulting firms in this region contributed towards the growth in this region.
Asia Pacific is anticipated to witness lucrative growth over the forecast period. Low cost of manufacturing and availability of qualified labor is likely to foster contract manufacturing in this region. Moreover, economic policy reforms in countries such as India and China are anticipated to create open and balanced economy, which presents ample opportunity for market players to invest in this region.
In 2017, the global Biotechnology/Pharmaceutical Services Outsourcing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.
The key players covered in this study
Quantic Group
QuintilesIMS
Parexel International Corporation
Lachman Associates
GMP Pharmaceuticals
Management Forum
Quality Context
Inspired Pharma
Concept Heidelberg GmbH
RSSL
Market segment by Type, the product can be split into
Consulting
Auditing & Assessment
Regulatory Affairs
Product Maintenance
Product Design & Development
Product Testing & Validation
Training & Education
Others
Market segment by Application, split into
Regenerative Medicine
Biobanking
Drug Discovery
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Biotechnology/Pharmaceutical Services Outsourcing status, future forecast, growth opportunity, key market and key players.
To present the Biotechnology/Pharmaceutical Services Outsourcing development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Biotechnology/Pharmaceutical Services Outsourcing are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
When it comes to pharmaceutical research and development however, success is never guaranteed. The average cost of drug development can reach into the billions of dollars, and it takes an average of 10 years to bring a new drug to market. In addition, many drugs fail to be clinical effective and subsequently never see the light of day.
Due to these risks, pharmaceutical companies are not always eager to utilize their onsite resources for drug R&D. Certain cost-saving measures implemented in the pharmaceutical space have included outsourcing these activities, helping organizations reduce both their operational and manufacturing costs, thereby lowering financial risk.
North America held more than 50.0% share for the pharmaceutical/biotechnology services outsourcing market in 2015. The presence of several multinational and local consulting firms in this region contributed towards the growth in this region.
Asia Pacific is anticipated to witness lucrative growth over the forecast period. Low cost of manufacturing and availability of qualified labor is likely to foster contract manufacturing in this region. Moreover, economic policy reforms in countries such as India and China are anticipated to create open and balanced economy, which presents ample opportunity for market players to invest in this region.
In 2017, the global Biotechnology/Pharmaceutical Services Outsourcing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.
The key players covered in this study
Quantic Group
QuintilesIMS
Parexel International Corporation
Lachman Associates
GMP Pharmaceuticals
Management Forum
Quality Context
Inspired Pharma
Concept Heidelberg GmbH
RSSL
Market segment by Type, the product can be split into
Consulting
Auditing & Assessment
Regulatory Affairs
Product Maintenance
Product Design & Development
Product Testing & Validation
Training & Education
Others
Market segment by Application, split into
Regenerative Medicine
Biobanking
Drug Discovery
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Biotechnology/Pharmaceutical Services Outsourcing status, future forecast, growth opportunity, key market and key players.
To present the Biotechnology/Pharmaceutical Services Outsourcing development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Biotechnology/Pharmaceutical Services Outsourcing are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
